首页> 外文OA文献 >Some considerations on urinary glucaric acid, especially on the relationship between glucaric acid and beta-glucuronidase activity in urine after intravenous administration of xylitol
【2h】

Some considerations on urinary glucaric acid, especially on the relationship between glucaric acid and beta-glucuronidase activity in urine after intravenous administration of xylitol

机译:尿木糖醛酸的一些注意事项,尤其是木糖醇静脉注射后尿液中的草甘膦酸与β-葡萄糖醛酸苷酶活性之间的关系

摘要

Since these 3 or 4 years the interrelationship between glucaric acid andβ -glucuronidase in urine has been stressed in Japan; and considerably many investigators have regarded the urinary glucaric acid as an index of inhibitory agents toβ-glucuronidase in urine, the conversion rate of glucosaccharo 1 • 4, 3 •6 dilactone into glucaric acid as an index to distinguish bladder cancer from others, and the programmed increase of urinary glucaric acid as an excellent therapeutic method of bladder cancer. To confirm these findings and hypothesis, a series of clinical studies were carried out and the following results were obtained. 1. The decreased excretion of glucaric acid in urine and the decreased conversion rate of glucosaccharo 1• 4, 3• 6 dilactone into glucaric acid in urine were considered as the characteristics of bladder cancer, but were found, also, in traumatic paraplegics. So it was difficult to say these findings were specific in carcinoma of the bladder. 2. Suppression of urinary glucaric acid after glucosaccharo 1 • 4, 3 • 6 dilactone or glucuronolactone administration was observed in some of traumatic paraplegics. It was difficult to explain these findings by the present metabolic map. 3. Marked decrease of glucaric acid in urine ensued after intravenous administration of xylitol 50 g (10% 500 ml) in almost all of the cases. 4. Urinary β-glucuronidase activities were decreased in about half of cases administered glucosaccharo 1 • 4, 3• 6 dilactone and xylitol. 5. Xylitol administration resulted in the decrease of urinaryβ-glucuronidase accompanied with the decrease of urinary glucaric acid. If the above-mentioned hypothesis that glucaric acid was an index of β-glucuronidase inhibition were valid, it would be impossible to explain these findings. So it was rather rational to consider that glucaric acid and β-glucuronidase in urine were independent each other. Namely, the close interrelationship between glucaric acid and β-glucuronidase had to be considered as a fallacy.
机译:自这3或4年以来,日本一直强调葡糖二酸与尿液中β-葡萄糖醛酸苷酶之间的相互关系。许多研究者认为尿葡糖二酸是尿液中β-葡萄糖醛酸苷酶抑制剂的指标,葡糖二糖1•4,3•6己内酯向葡糖二酸的转化率是区分膀胱癌和其他膀胱癌的指标。尿中葡糖二酸的有计划的增加是膀胱癌的一种极好的治疗方法。为了证实这些发现和假设,进行了一系列临床研究并获得了以下结果。 1.尿液中葡糖二酸的排泄减少和尿糖中的葡萄糖1–4、3•6二内酯向尿酸中的葡糖二酸的转化率降低被认为是膀胱癌的特征,但在创伤性截瘫患者中也被发现。因此很难说这些发现是膀胱癌特有的。 2.在一些创伤性截瘫患者中观察到葡萄糖苷1•4,4,3•6双内酯或葡萄糖醛酸内酯给药后尿中草甘膦酸的抑制。目前的代谢图很难解释这些发现。 3.在几乎所有情况下,静脉注射木糖醇50克(10%500毫升)后,尿液中的草甘膦酸含量均明显降低。 4.大约一半的患者在服用1、4、3、6双内酯葡萄糖和木糖醇的情况下尿中β-葡萄糖醛酸苷酶活性降低。 5.木糖醇给药导致尿β-葡糖醛酸糖苷酶减少,同时尿葡糖二酸减少。如果上述关于葡糖二酸是抑制β-葡萄糖醛酸苷酶的指标的假设成立,那么就不可能解释这些发现。因此,认为尿液中的葡糖二酸和β-葡萄糖醛酸苷酶彼此独立是很合理的。即,必须将葡糖二酸和β-葡糖醛酸糖苷酶之间的紧密相互关系视为谬误。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号